AngioDynamics Inc (ANGO) income statement
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/3011% below fair value
$11.49−0.29 (-2.46%)
Close on Nov 17, 2026Market cap $483.21MP/E –Yield –
AngioDynamics Inc income statement
Ratios
Latest available, balances at Aug 31, 2026
Profitability, TTM
- Gross margin
- 55.7%
- Operating margin
- -11.2%
- Net margin
- -10.1%
- Return on equity, FY2026
- -20.8%
Financial strength
- Current ratio
- 2.40
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 56.9%
Valuation
- P/E ratio
- –
- Price to sales
- 1.49
- Price to book
- 2.95
- Dividend yield
- –
See a number that looks wrong?